News and press releases

Streamlining development and assessment of biosimilar medicines

EMA is exploring improvements to the development and evaluation of biosimilar medicines, while upholding strict European Union (EU) safety standards. With over two decades of…

Apr 1, 2025 - 14:08
 0
Streamlining development and assessment of biosimilar medicines
EMA is exploring improvements to the development and evaluation of biosimilar medicines, while upholding strict European Union (EU) safety standards. With over two decades of…
Read More

Tags:

Previous Article

Trump administration to shut down CMS, HHS minority health offices amid restruct...

Next Article

STAT+: Trump’s proposed tariffs may cause shortages of Canadian-made drugs in th...

Related Posts

Unregulated advanced therapy medicinal products pose serious risks to health

Unregulated advanced therapy medicinal products pose se...

Mar 13, 2025  0

EMA establishes regular procedure for scientific advice on certain high-risk medical devices

EMA establishes regular procedure for scientific advice...

Feb 10, 2025  0

Two new vaccines against bluetongue recommended for approval

Two new vaccines against bluetongue recommended for app...

Feb 9, 2025  0